Plaque rupture is the breaking open of a fatty deposit inside an artery wall, exposing its contents to the bloodstream and triggering a blood clot that can cause a heart attack or stroke. It is the single most common cause of heart attacks, responsible for roughly 73% of coronary artery blood clots. Understanding how and why it happens helps explain why some people with no prior symptoms can have a sudden cardiac event.
How Plaque Builds Up in Arteries
Plaque rupture doesn’t happen overnight. It begins years or even decades earlier, when cholesterol particles (LDL) pass through a damaged spot in the artery lining and lodge in the vessel wall. Once trapped, those particles get oxidized by free radicals, which sets off an immune response. White blood cells called macrophages rush in to clean up the oxidized cholesterol but end up gorging on it, becoming bloated “foam cells” that accumulate into a soft, fatty core inside the artery wall.
Over time, a layer of smooth muscle cells and collagen forms over this fatty core like a protective shell. This shell is called the fibrous cap. As long as the cap stays thick and intact, the plaque is considered stable. It may narrow the artery and cause symptoms like chest pain during exercise, but it’s unlikely to cause a sudden heart attack. The danger starts when that cap begins to weaken.
What Makes a Plaque Vulnerable
Not all plaques are equally dangerous. The ones most likely to rupture share a specific set of features: a large, soft lipid core, a thin fibrous cap, and heavy infiltration by inflammatory cells. Cardiologists call this type of plaque a “thin-cap fibroatheroma.” In imaging studies, the fibrous cap on these high-risk plaques measures less than 65 micrometers thick, roughly the width of a human hair. The lipid core typically occupies more than 55% of the plaque’s cross-section, leaving very little structural support.
The critical difference between a stable plaque and a vulnerable one isn’t necessarily size. Many plaques that rupture cause only mild narrowing of the artery beforehand. Imaging studies performed about a year before heart attacks often show the future culprit artery had less than 50% blockage with smooth-looking walls. That’s why plaque rupture can strike people who had no warning signs.
The Enzymes That Weaken the Cap
The fibrous cap gets its strength from collagen, the same protein that gives structure to skin and tendons. The cap weakens when collagen is broken down faster than it can be replaced. Immune cells inside the plaque, particularly macrophages and activated T cells, drive this process by releasing a family of enzymes called metalloproteinases (MMPs). At least five types of these enzymes can directly cut through the collagen fibers that hold the cap together.
Inflammatory signals ramp up production of these enzymes. Molecules like tumor necrosis factor, interleukin-1, and oxidized LDL cholesterol all push macrophages to produce more MMPs. At the same time, activated T cells release a chemical signal that tells smooth muscle cells to stop making new collagen. So the cap is being chewed apart from within while its repair system is shut down. Eventually, the cap becomes too thin to withstand the mechanical forces of blood flow and blood pressure, and it tears open.
What Happens When the Cap Breaks
The moment a plaque ruptures, the soft, fatty core is exposed to flowing blood. This core contains proteins that are powerfully clot-promoting, especially a molecule called tissue factor. Tissue factor latches onto clotting proteins in the blood and kicks off a chain reaction of coagulation. Simultaneously, collagen and other structural proteins from the damaged wall attract platelets, the small cell fragments responsible for plugging wounds.
The two processes reinforce each other. Platelets pile up at the rupture site and provide a surface where more clotting reactions can take place. The clotting cascade produces thrombin, an enzyme that converts a dissolved blood protein into fibrin, which forms a mesh that stabilizes the growing clot. Thrombin also activates still more platelets, creating a feedback loop that can rapidly enlarge the clot. If the clot grows large enough, it can partially or completely block the artery.
Complete blockage of a coronary artery starves the heart muscle of oxygen, causing a heart attack. In a brain artery, the same process causes a stroke. Sometimes a clot breaks loose and travels downstream to block a smaller vessel instead.
Rupture Doesn’t Always Mean Instant Heart Attack
One important finding is that the timeline from rupture to full arterial blockage isn’t always minutes or hours. A study published in Circulation found that when coronary angiograms were performed just three days before a heart attack, 60% of the soon-to-be-blocked arteries already showed signs of plaque disruption and clot formation, and the narrowing had already progressed to over 70%. Yet a year earlier, those same arteries typically had only mild, smooth-walled narrowing of about 30%.
This suggests that plaque rupture can be a smoldering process. A small rupture may form a clot that partially dissolves or gets incorporated into the plaque, causing it to grow. Repeated cycles of rupture, clotting, and healing can gradually worsen blockage over days or weeks before a final event seals the artery shut. Some ruptured plaques heal completely without ever causing symptoms.
How Doctors Detect Vulnerable Plaques
Standard tests like stress tests and traditional angiograms reveal how narrow an artery has become, but they can’t see inside the plaque to assess whether it’s stable or about to rupture. Specialized imaging tools used during catheterization can get closer to that answer.
Optical coherence tomography (OCT) uses near-infrared light to produce extremely detailed images of the artery wall and can directly measure fibrous cap thickness. Intravascular ultrasound (IVUS) provides a broader view of plaque size and composition but has lower resolution. Neither tool alone captures every feature of a vulnerable plaque, so combining them improves accuracy. When researchers paired ultrasound-based tissue analysis with OCT cap measurement, diagnostic accuracy for identifying the most dangerous plaques reached 89%.
These imaging tools are currently used during procedures for patients who already have coronary artery disease. They aren’t yet part of routine screening for people without symptoms.
Stabilizing Plaques to Prevent Rupture
The most effective proven strategy for preventing plaque rupture is cholesterol-lowering therapy, particularly statins. Statins work on multiple fronts. They lower the amount of LDL cholesterol available to feed the plaque’s fatty core, but they also have direct effects on the plaque itself. Animal and human studies show that statins increase the collagen content of the fibrous cap, reduce the amount of lipid in the core, decrease the number of inflammatory macrophages inside the plaque, and lower the activity of the enzymes that chew through collagen.
An OCT imaging study found that patients already taking statins had dramatically lower rates of plaque rupture at the site responsible for their heart event: 8% compared to 36% in patients not on statin therapy. Those on statins also showed a trend toward thicker fibrous caps, averaging 78 micrometers versus 49 micrometers, which pushes the cap above the critical danger threshold. Prospective studies using ultrasound analysis have confirmed that statin-treated patients show shrinking lipid volumes and growing fibrous tissue within their plaques over time.
Beyond statins, controlling blood pressure reduces the mechanical stress on vulnerable caps. Managing blood sugar, not smoking, and staying physically active all reduce the chronic inflammation that drives the enzymes responsible for cap thinning. These aren’t just general wellness recommendations. Each one targets a specific step in the biological chain that leads from stable plaque to ruptured plaque to blood clot.